skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I was just looking at VBNK. The company's performance data looks extremely compelling, And also company insider buying is extensive ; more than what I ever recall seeing on any of the companies I follow. Could you please provide me with an analysis of the investment merits of the company. Also could you compare this company for potential purchase with EQB. What would be your preference, or would a position in both be advisable? Thanks.
Read Answer Asked by John on March 08, 2024
Q: Digital Currency

With the long-rumored conversion of US currency to digital format, and presumably Canadian followup, what types of companies will most profit from these changes and what specific recommendations do you have? Are there any overall structural changes to handling a portfolio that you suggest?
Thanks for your ongoing great service.
Read Answer Asked by David on March 08, 2024
Q: I have read through your Macro Market Model information you forwarded yesterday and find it somewhat confussing.
I am subcribed to your Portfolio Analytics but when I go to the bottom of your How to Utilize it and where it says Free Report Download and click on it here is what I get,
Uh oh! We've encountered an error!
"The action you have requested could not be processed. Perhaps you have followed an incomplete link, or are using an old bookmark"?
I am not sure what this means?
If I also go to the Portfolio Analytics There is nothing there that makes reference to the "Macro Market Models".
Can you please clarify ! Thanks.
Read Answer Asked by Terry on March 08, 2024
Q: Will the Macro Market Models webinar be recorded so we can watch it later? If so do we need to register to get the recording?
Read Answer Asked by Lisa on March 08, 2024
Q: Having very little in technology in a pf and limited new funds are mag7 cdr’s a reasonable means of entering the sector?

If so what would be a reasonable buy point for each
Read Answer Asked by Barrie on March 08, 2024
Q: Can you comment on London listed Judges Scientific .Valuation and outlook….thx
Read Answer Asked by Kim on March 08, 2024
Q: Up to mid 2019, this stock was cruising on a gradual increase, then it doubled over the next 18 months. Now, some 38 months later, it is approaching where it was before it's 18 month growth spurt. I believe that you said the stock benefitted from increased interest in green energy, and that now that interest has waned. Would there be any more to describe the drop of some 42% over the past 3 years? Do you think the 6.3% dividend will be cut again? Thank you very much for your valuable perspective.
Read Answer Asked by TOM on March 08, 2024
Q: Hi 5i, and would welcome your review of the Quarterly results from illumin Holdings. Do you see any red flags or concerns with the recent performance and future business prospects conveyed? At a past point in time they had a large cash cushion that presumably provided a floor for the stock price, hence can you please comment on how they're using that cash recently. All things considered, do you see any rays of sunshine, and could you consider it a hold or a little better?
Read Answer Asked by Michael on March 08, 2024
Q: These stocks have had some very nice gains over the last few months. CLS, DE, DRX, EQB, LMN, PAY, TOI, TVK. If you held a partial position in these and wanted to add to the position to create a full position, which ones would you just buy at the current market price despite big run up? Are there some that you would try to buy at a somewhat lower price? If so, what price would you use?
Read Answer Asked by Dan on March 08, 2024
Q: For capital appreciation over a 5 year period - Which 2 or 3 of the listed stocks would you choose.
Thanks
Read Answer Asked by Gary on March 08, 2024
Q: PFE share price is at a low for the past 10 years. It has a low PE with an attractive dividend that pays while you wait. Is the growth profile really that bad that it should be falling out of bed? My suspicion is that in reverting to the mean following the Covid revenue burst the market has overshot and it is unduly punishing the stock. This would represent an excellent buying opportunity, no?
Read Answer Asked by Benjamin on March 08, 2024